Company: UPC
Filing Date: 2025-01-27
Form Type: NT 20-F
Source: 0001213900-25-006745
Chunk: 2

Company: Universe Pharmaceuticals INC
Filing Date: 2025-01-27
Form: NT 20-F
Chunk 2
---
 compared to those for the fiscal year
ended September 30, 2023.

Specifically, (i) the Registrant’s revenue
for the year ended September 30, 2024 is expected to be approximately $23.02 million, a decrease of approximately $9.28 million, or 28.7%,
from approximately $32.31 million for the fiscal year ended September 30, 2023; (ii) the Registrant’s gross profit for the year
ended September 30, 2024 is expected to be approximately $6.07 million, a decrease of approximately $4.24 million, or 41.1%, from approximately
$10.32 million for the fiscal year ended September 30, 2023; and (iii) the Registrant’s net loss for the fiscal year ended September
30, 2024 is expected to be approximately $20.33 million, an increase of approximately $14.16 million, as compared to a net loss of $6.16
million for the fiscal year ended September 30, 2023.

Forward-Looking Statements

This notification includes forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. The word “expects,” “anticipates” and similar terms and phrases are used in this notification to identify
forward-looking statements. Risks, uncertainties and assumptions that could affect the Registrant’s forward-looking statements include,
among other things, any changes to the Registrant’s anticipated financial results as a result of the Registrant’s independent
registered public accounting firm completing its audit of the Registrant’s financial statements, the Registrant’s ability
to complete and file future periodic filings with the U.S. Securities and Exchange Commission on a timely basis and other risks and uncertainties
discussed more fully in the Registrant’s filings with the U.S. Securities and Exchange Commission.

<div align='center'>1

(Name of Registrant as Specified in Charter)</div>

has caused this notification to be signed on its
behalf by the undersigned hereunto duly authorized.

| Date: January 27, 2025 |        |                         |
|:-----------------------|:-------|:------------------------|
|                        | By:    | /s/ Gang Lai            |
|                        | Name:  | Gang Lai                |
|                        |